SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-15-002642
Filing Date
2015-11-12
Accepted
2015-11-12 17:15:16
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q zyne-20150930x10q.htm 10-Q 980677
2 EX-31.1 zyne-20150930ex311394ffb.htm EX-31.1 11314
3 EX-31.2 zyne-20150930ex3126fe4bc.htm EX-31.2 11104
4 EX-32.1 zyne-20150930ex321fa1a93.htm EX-32.1 7064
5 EX-32.2 zyne-20150930ex3229943ea.htm EX-32.2 7149
  Complete submission text file 0001558370-15-002642.txt   3636626

Data Files

Seq Description Document Type Size
6 EX-101.INS zyne-20150930.xml EX-101.INS 681314
7 EX-101.SCH zyne-20150930.xsd EX-101.SCH 22256
8 EX-101.CAL zyne-20150930_cal.xml EX-101.CAL 31096
9 EX-101.DEF zyne-20150930_def.xml EX-101.DEF 106774
10 EX-101.LAB zyne-20150930_lab.xml EX-101.LAB 237954
11 EX-101.PRE zyne-20150930_pre.xml EX-101.PRE 211833
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37526 | Film No.: 151225885
SIC: 2834 Pharmaceutical Preparations